Neurologic dysfunction in gastrointestinal disease

Seminars in Neurology

Volumn 16, Issue 3, 1996, Pages 217-226

  Pfeiffer, Ronald F ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DIARRHEA; CELIAC DISEASE; DIGESTIVE SYSTEM CANCER; ENTERITIS; GASTROINTESTINAL DISEASE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; STOMACH SURGERY; WILSON DISEASE;

EID: 0030425823     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040978     Document Type: Review

References (124)

1. Podolsky DK. Inflammatory bowel disease (first of two parts). N Engl J Med 1991;325:928-36
2. Snook JA, de Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. Q J Med 1989;72:835-40
3. Spiro HM. Clinical gastroenterology, 4th ed. New York: McGraw-Hill, 1993:633-759
4. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976;55:401-12
5. Lossos A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995;45:416-21
6. Nemni R, Fazio R, Corbo M, et al. Peripheral neuropathy associated with Crohn's disease Neurology 1987;37:1414-7
7. Humbert P, Monnier G, Billerey C, et al. Polyneuropathy: an unusual extraintestinal manifestation of Crohn's disease. Acta Neurol Scand 1989;80:301-6
8. Gendelman S, Present D, Janowitz HD. Neurological complications of inflammatory bowel disease. (Abstract ) Gastroenterology 1982;82:1065
9. Griffin JW, Ho TW The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann Neurol 1993;34:125-7
10. 1 IgG antibodies and Campylobacter in Guillain-Barré syndrome: evidence of molecular mimicry. Ann Neurol 1995;38:170-5
11. Podolsky DK. Inflammatory bowel disease (second of two parts) N Engl J Med 1991;325:1008-16
12. Zimmerman J, Steiner I, Gavish D, Argov Z. Guillain-Barré syndrome: a possible extraintestinal manifestation of ulcerative colitis. J Clin Gastroenterol 1985;7:301-3
13. Greene RM, Rogers RS III. Melkersson-Rosenthal syndrome, a review of 36 patients. J Am Acad Dermatol 1989;21:1263-70
14. Lloyd DA, Payton KB, Guenther L, Frydman W. Melkersson-Rosenthal syndrome and Crohn's disease: one disease or two? Report of a case and discussion of the literature. J Clin Gastroenterol 1994;18:213-7
15. Summers RW, Harker L. Ulcerative colitis and sensorineural hearing loss: is there a relationship? J Clin Gastroenterol 1982;4:251-2
16. Hollanders D. Sensorineural deafness - a new complication of ulcerative colitis? Postgrad Med J 1986;62:753-5
17. Hollanders D, Vadheim CM, Brettholtz E, et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986;105:883-5
18. Bhigjee AI, Bill PLA, Cosnett JE. Ulcerative colitis and interstitial myositis. Clin Neurol Neurosurg 1987;89:261-3
19. Kaneoka H, Iyadomi I, Hiida M, et al. An overlapping case of ulcerative colitis and polymyositis. J Rheum 1990;17:274-6
20. Chugh S, Dilwari JB, Sawhney IMS, et al. Polymyositis associated with ulcerative colitis. Gut 1993;34:567-9
21. Leibowitz G, Eliakim R, Amir G, Rachmilewitz D. Dermatomyositis associated with Crohn's disease. J Clin Gastroenterol 1994;18:48-52
22. Menard DB, Haddad H, Blain JG, et al. Granulomatous myositis and myopathy associated with Crohn's disease. N Engl J Med 1976;295:818-9
23. Riggs JE. Neurological consequences of systemic diseases. In Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds: Neurology in clinical practice, 1st ed, Boston: Butterworth-Heinemann 1991:841-60
24. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clinic Proc 1986;61:140-5
25. Markowitz RL, Ment LR, Gryboski JD. Cerebral thromboembolic disease in pediatric and adult inflammatory bowel disease: case report and review of the literature. J Pediatr Gastroenterol Nutr 1989;8:413-20
26. Nelson J, Barren MM, Riggs JE, et al. Cerebral vasculitis and ulcerative colitis. Neurology 1986;36:719-21
27. Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis. Lancet 1982;2:555
28. Spiro HM. Clinical gastroeterology, 4th ed New York: McGraw-Hill, 1993:441-61
29. Lycke N, Kilander A, Nilsson L-A, et al. Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level. Gut 1989;30: 72-7
30. Trier JS. Celiac sprue. N Engl J Med 1991;325:1709-19
31. Brasitus TA, Sitrin MD. Intestinal malabsorption syndromes. Annu Rev Med 1990;41:339-47
32. Bardella MT, Molteni N, Cesana B, et al. IgA antigliadin antibodies, cellobiose/mannitol sugar test, and carotenemia in the diagnosis of and screening for celiac disease. Am J Gastroenterol 1991;86:309-11
33. Ward ME, Murphy JT, Greenberg GR. Celiac disease and spinocerebellar degeneration with normal vitamin E status. Neurology 1985;35:1199-201
34. Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease Brain 1966;89:683-722
35. Finelli PF, McEntee WJ, Ambler M, Kestenbaum D. Adult coeliac disease presenting as a cerebellar syndrome. Neurology 1980;30:245-9
36. Kinney HC, Burger PC, Hurwitz BJ, et al Degeneration of the central nervous system associated with celiac disease. J Neurol Sci 1982;53:9-22
37. Goranson G, Norden A, Akesson B. Low plasma tocopherol levels in patients with gastrointestinal disorders. Scand J Gastroenterol 1973;8:21-5
38. Dohan FC. More on celiac disease as a model for schizophrenia. Biol Psychiatry 1983;18:561-4
39. Rowe DB, Walls TJ. Gait ignition failure, cognitive impairment and celiac disease a case report. (Abstract.) Mov Disord 1996:11 (Suppl 1):123
40. Hadjivassiliou M, Gibson A, Davies-Jones GAB, Sagar HJ, Cryptic gluten sensitivity: An important cause of ataxia? (Abstract.) Mov Disord 1996:11 (Suppl 1):42
41. Cooke WT, Johnson AG, Woolf AL Vital stamina and electron microscopy of the intramuscular nerve endings in the neuropathy of adult coeliac disease. Brain 1966;89:663-82
42. Collin P, Pirttilä T, Nurmikko T, et al. Celiac disease, brain atrophy, and dementia. Neurology 1991;41:372-5
43. Chapman RWG, Laidlow JM, Colin-Jones D, et al. Increased prevalence of epilepsy in coeliac disease. BMJ 1978;2:250-1
44. Toti P, Balestri P, Cano M, et al. Celiac disease with cerebral calcium and silica deposits, x-ray spectroscopic findings, an autopsy study. Neurology 1996;46:1088-92
45. Rush PJ, Inman R, Bernstein M, et al. Isolated vasculitis of the central nervous system in a patient with celiac disease. Am J Med 1986;81:1092-4
46. Spiro HM. Clinical gastroenterology. 4th ed. New York: McGraw-Hill, 1993:525-55
47. Ho T-W, Cornblath DR, Li C-Y, et al. Patterns of recovery in different forms of the Guillain-Barré syndrome associated with Camplyobacter jejuni. (Abstract) Ann Neurol 1995;38:336
48. 1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16
49. Gregson NA, Koblar S, Hughes RAC. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med 1993;86:111-7
50. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-44
51. 1 BD1b. peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34: 130-5
52. Spiro HM. Clinical gastroenterology, 4th ed. New York: McGraw-Hill, 1993:329-39
53. Arbarbanel JM, Berginer VM, Osimani A, et al. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology 1987;37:196-200
54. Haid RW, Gutman L, Crosby TW. Wernicke-Korsakoff encephalopathy after gastric plication. JAMA 1982;247:2566-7
55. Oczkowski WJ, Kertesz AK. Wernicke's. encephalopathy after gastroplasty for morbid obesity. Neurology 1985;35:99-101
56. McLean JB. Wernicke's encephalopathy after gastric plication. JAMA 1982;248:1311
57. Feit H, Glasberg M, Ireton C. Peripheral neuropathy and starvation after sastric partitioning for morbid obesity. Ann Intern Med 1982;96:453-5
58. Paulson GW, Mojzisik C, Carrey L, Martin E. Neurological complications of gastric stapling for morbid obesity. (Abstract.) Neurology 1983:33(Suppl 2):190
59. Posner JB. Neurologic complications of cancer. Philadelphia: FA Ddvis, 1995
60. Enevoldson TP, Ball JA, McGregor JM. Resolution of a severe sensorimotor neuropathy following resection of an associated asymptomatic gastric lymphoma. J Neurol Neurosurg Psychiatry 1990;53:267-8
61. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600
62. Lasser DM, DeVivo DC, Garvin J, Wilhelmsen KC. Turcot's syndrome: evidence for linkage to the adenomatous polyposis coli (APC) locus Neurology 1994;44:1083-6
63. Gilliland BC. Systemic sclerosis (scleroderma). In Isselbacher KJ, Braunwald E, Wilson JD, et al. eds: Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994. 1655-61
64. Averbuch-Heller L, Steiner I, Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 1992; 49:1292-5
65. Crystal RG. Sarcoidosis. In Isselbacher KJ, Braunwald E, Wilson JD, et al, eds. Harrison's principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994:1679-84
66. Luke RA, Stern BJ, Krumholz Z, Johns CJ. Neurosarcoidosis: the long-term clinical course. Neurology 1987;37:461-3
67. Weiner SR, Utsinger P. Whipple disease. Semin Arthritis Rheum 1986;15 157-67
68. Dobbins WO III Whipple's disease. Springfield, IL. Charles C Thomas, 1987
69. Donaldson RM. Whipple's disease - rare malady with uncommon potential. N Engl J Med 1992;327:346-8
70. Relman DA, Schmidt T.M. MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327:293-301
71. Adams M, Rhyner PA, Day J, et al. Whipple's disease confined to the central nervous system. Ann Neurol 1987;21:104-8
72. Knox DL, Green WR, Troncoso JC, et al. Cerebral ocular Whippie's disease: a 62-year odyssey from death to diagnosis. Neurology 1995;45:617-25
73. Schwartz MA, Selhorst JB, Ochs AL, et al. Oculomasticatory myorthythmia a unique movement disorder occurring in Whipple's disease. Ann Neurol 1986;20:677-82
74. Swash M, Schwartz MS, Vandenburg MJ, Pollock DJ. Myopathy in Whipple's disease. Gut 1977;18 800-4
75. Desnick RJ. The porphyrias. In Isselbacher KJ, Braunwald E, Wilson JD, et al. eds: Harrison's principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994:2073-9
76. Bosch EP, Mitsumoto H. Disorders of peripheral nerves. In Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds: Neurology in clinical practice. 1st ed. Boston: Butterworth-Heinemann, 1991:1719-818
77. King PH, Bragdon AC. MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria. Neurology 1991;41:1300-2
78. Lockwood AH. Hepatic encephalopathy and other neurological disorders associated with gastrointestinal disease. In Aminoff MJ, ed: Neurology and general medicine, 2nd ed. New York: Churchill Livingstone, 1995:247-66
79. Ede RJ, Williams R. Hepatic encephalopathy and cerebral edema. Semin Liver Dis 1986;6:107-18
80. Spiro HM. Clinical gastroenterology, 4th ed. New York: McGraw-Hill, 1993:1153-205
81. Sherlock S. Pathosenesis and management of hepatic coma. Am J Med 1958;24:805-13
82. Kulisevsky J, Pujol J, Junqué C, et al. MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 1993;43:2570-3
83. Kulisevsky J, Pujol J, Junqué C, et al. Persistence of MRI hyperintensity of the globus pallidus in cirrhotic patients: a 2-year follow-up study. Neurology 1995;45:995-7
84. Hauser RA, Zesiewicz TA, Rosemurgy AS, et al. Manganese intoxication and chronic liver failure. Ann Neurol 1994; 36:871-5
85. Lockwood AH. Hepatic encephalopathy Boston Butterworth-Heinemann, 1992
86. McDermott WV Jr. Wareham J, Riddell AG. Treatment of "hepatic coma" with L-glutamic acid. N Engl J Med 1955; 253:1093-1102
87. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2:75-80
88. A) receptor complex and hepatic encephalopathy. Ann Intern Med 1989;110:532-46
89. McClain CJ, Zieve L, Doizaki WM, et al. Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy. Gut 1980;21:318-23
90. Muto YI. Clinical study on the relationship of short chain fatty acids and hepatic encephalopathy. Jpn J Gastroenterol 1966; 63:19
91. Hendrickse MT, Triger DR. Peripheral and cardiovascular autonomic impairment in chronic liver disease: prevalence and relation to hepatic function. J Hepatol 1992;16:177-83
92. Fleckenstein JF, Frank SM, Thuluvath PJ. Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 1996;23:471-5
93. Hendrickse MT, Thuluvath PJ, Triger DR Natural history of autonomic neuropathy in chronic liver disease Lancet 1992; 339:1462-4
94. Pujol A, Graus F, Rimola A, et al. Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994;44:1226-30
95. Stein DP, Lederman RJ, Vogt DP, et al. Neurological complications following liver transplantation Ann Neurol 1992; 31:644-9
96. Wszolek ZK, Fulgham JR. Neurological compilations follow ing liver transplantation In Maddrey WC, Sorrell MF, eds: Transplantation of the liver. Norwalk: Appleton and Lange. 1993-399-425
97. Martinez AJ, Estol C, Paris AA. Neurologic complications of liver transplantation. Neurol Clin 1988;6:327-18
98. Wszolek ZK, Aksamit AJ, Ellingson RJ, et al Epileptiform electroencephalographic abnormalities in liver transplant recipients. Ann Neurol 1991;30:37-41
99. Estol CJ, Lopez O, Brenner RP, Martinez AJ. Seizures after liver transplantation: a clinicopathologic study. Neurology 1989; 39:1297-301
100. Wszolek ZK, Steg RE. Seizures after liver transplantation. Liver Transplant Surg 1995;1:334-9
101. Boes B, Bashir R, McComb R, McConnell J. CNS aspergillosis: review of twenty-six patients. (Abstract.) Neurology 1991; 42(Suppl 3).458
102. Krom RAF, Wiesner RH, Rettke SR, et al. The first 100 liver transplantations at the Mayo Clinic. Mayo Clinic Proc 1989; 64:84-94
103. Rowley HA, Kaku DA, Ascher NL, et al. Neurologic findings in 100 consecutive liver transplant recipients (Abstract.) Neurology 1990;40(suppl 1):181
104. Martinez AJ, Ahdab-Barmada M. The neuropathology of liver transplantation: comparison of main complications in children and adults Mod Pathol 1993;6:25-32
105. Créange A, Gray F, Cesaro P, et al. Creutzfeldt-Jakob disease after liver transplantation. Ann Neurol 1995;38:269-72
106. Wszolek ZK, McComb RD, Pfeiffer RF, et al. Pontine and extrapontine myelinolysis following liver transplantation: relationship to serum sodium. Transplantation 1989;48:1006-12
107. Wijdicks EFM, Wiesner RH, Krom RAF. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 1995;45:1962-4
108. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporine A-induced neurotoxicity. Am J Neuroradiol 1991;12:651-9
109. deGroen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987;317:861-6
110. Thompson CB, June CH, Sullivan KM, Thomas ED Association between cyclosporin neurotoxicity and hypomagnesemia. Lancet 1984;2:1116-20
111. Taylor BV, Wijdicks EFM, Poterucha JJ, Weisner RH. Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation. Ann Neurol 1995;38:828-31
112. Scheinberg IH, Sternlieb I. Wilson's disease. Philadelphia. WB Saunders. 1984
113. O'Reilly S, Weber PM, Oswald M, Shipley L. Abnormalities of the physiology of copper in Wilson's disease. Arch Neurol 1971;25:28-32
114. Bull PC, Thomas GR, Rommens JM, et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet 1993;5:327-37
115. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197:271-7
116. Pfeiffer RF, Ebadi M. Wilson's disease. In Stern MB, Koller WC. eds: Parkinsonian syndromes, New York: Marcel Dekker, 1993:321-10
117. Walshe JM, Wilson's disease (HLD). In Vinken PJ, Bruyn GW, eds: Handbook of clinical neurology, Vol 27. Amsterdam: North Holland, 1976:379-414
118. Strickland GT, Leu ML. Wilson's disease. Clinical and laboratory manifestations in 40 patients. Medicine 1975;54:113-37
119. Walshe JM. Wilson's disease. The presenting symptoms. Arch Dis Child 1962;37:253-6
120. Dening TR, Berrios GE, Walshe JM. Wilson's disease and epilepsy. Brain 1988;111:1139-55
121. Golding DN, Walshe JM. Arthropathy of Wilson's disease. Study of clinical and radiological features in 32 patients. Ann Rheum Dis 1977;36 99-111
122. McIntyre N, Clink HM, Levi AJ, et al Hemolytic anemia in Wilson's disease N Engl J Med 1967;276:439-44
123. Victor M, Adams RD, Cole M. The acquired (non-wilsonian) type of chronic hepatocerebral degeneration. Medicine 1965; 44:345-96
124. Jog MS, Lang AE. Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 1995; 10:714-22